Watch the webcast here!
Analyst Q&A: Shanon Trueman
Fast food chains have been jumping on the healthy food bandwagon with varying success for some time now. Enhancing their menus with foods featuring lower fat, lower cholesterol, and lower sodium, the idea is to bolster sales and invite a new demographic into their restaurants. The anti-obesity drive is also affecting fast food restaurant menus. In 2002, a man sued McDonald’s and other fast food restaurants, claiming that he became obese eating a steady diet of their high-fat foods. The suit was dismissed, but the publicity around it was damaging, contributing to declines in fast food sales for a time.
Restaurants have attempted to add healthier items to their menus in the past, with some hits but a lot of misses, too. McDonald’s low-fat beef burger, the McLean, flopped. Pizza Hut’s addition of lower-fat pizza toppings failed. Then, things started to turn around. For example, Burger King’s grilled chicken sandwich, the BK Broiler (now called the Tendergrill), was more successful.
The global market for biotechnology represents a large and complex amalgamation of different products that touches many different industry segments. In the healthcare industry alone, biologics represent a greater than $125 billion global market, and biosimilars legislation in the US and EU has spawned new generic biologics markets that will continue to grow. In addition, the even larger and more rapidly growing market for personalized medicine is driving biotechnology-based diagnostic and health management tools. In the agricultural industries, the market for genetically modified seeds and crops that are pest and disease resistant continues to grow. In the energy industries, large rounds of funding continue to drive the development of biofuels, the quality and production of which is likely to be improved by biotechnological advances. Participants in all of these markets rely on positive innovations and intellectual property (IP) rights to maintain and grow their market shares.Read more
Issue: Client engaged Nerac for an independent, third party assessment of their turbo expander in place of throttle valves at letdown stations for natural gas distribution Read more
Issue: A client which utilizes a large number of diesel engines wanted to explore the use of Jatropha oil in place of diesel fuel. Read more
Issue: A large petroleum company needed to understand the Intellectual Property relating to the use of supercritical fluids (SCFs) in chemical processing. Read more
Issue: Nerac was engaged by a senior business development executive from a medium-sized energy manufacturing company to investigate options for entry into the biofuels market through a strategic acquisition. Read more
Issue: The CEO of a large manufacturing company asked Nerac to provide an opinion on the advisability of engaging in a joint venture with a company in the field of concentrated photovoltaics (CPV). Read more
Issue: The Product Development Manager at a mattress manufacturer was looking for opportunities in new materials for mattress cushions. Read more
Issue: The Director of R&D at a world-wide manufacturing company was deciding whether to acquire the rights to distribute a coating nanotechnology process for food contact surfaces. The company enlisted Nerac’s help to vet the technology and the potential market opportunities. Read more.